The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis

Lawrence A Schachner, F. K. Bagatell, C. V. Whittington, I. Willis, J. Sefton, R. E. DeGryse

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Naftifine cream 1% was compared with its vehicle during a 6-week, double-blind, randomized, parallel-group study of 91 subjects with tinea pedis. After 4 weeks of twice-daily treatment, 57% of the subjects treated with naftifine and 38% of those treated with its vehicle had negative microscopic findings and negative fungal cultures (p=0.038). Two weeks after the conclusion of treatment (week 6), 62% of the naftifine group and 29% of the vehicle group had negative mycological findings (p=0.002). Naftfine was significantly more effective than its vehicle in reducing fungal scaling and fissuring (p<0.04). It was concluded that naftifine cream 1% is safe and significantly more effective than its vehicle in treating tinea pedis.

Original languageEnglish (US)
Pages (from-to)148-152
Number of pages5
JournalAdvances in Therapy
Volume7
Issue number3
StatePublished - 1990
Externally publishedYes

Fingerprint

Tinea Pedis
Safety
naftifine

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Schachner, L. A., Bagatell, F. K., Whittington, C. V., Willis, I., Sefton, J., & DeGryse, R. E. (1990). The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis. Advances in Therapy, 7(3), 148-152.

The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis. / Schachner, Lawrence A; Bagatell, F. K.; Whittington, C. V.; Willis, I.; Sefton, J.; DeGryse, R. E.

In: Advances in Therapy, Vol. 7, No. 3, 1990, p. 148-152.

Research output: Contribution to journalArticle

Schachner, LA, Bagatell, FK, Whittington, CV, Willis, I, Sefton, J & DeGryse, RE 1990, 'The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis', Advances in Therapy, vol. 7, no. 3, pp. 148-152.
Schachner LA, Bagatell FK, Whittington CV, Willis I, Sefton J, DeGryse RE. The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis. Advances in Therapy. 1990;7(3):148-152.
Schachner, Lawrence A ; Bagatell, F. K. ; Whittington, C. V. ; Willis, I. ; Sefton, J. ; DeGryse, R. E. / The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis. In: Advances in Therapy. 1990 ; Vol. 7, No. 3. pp. 148-152.
@article{c8e4c060316b4e249c2d855923bd8724,
title = "The safety and efficacy of naftifine cream 1{\%} in the treatment of tinea pedis",
abstract = "Naftifine cream 1{\%} was compared with its vehicle during a 6-week, double-blind, randomized, parallel-group study of 91 subjects with tinea pedis. After 4 weeks of twice-daily treatment, 57{\%} of the subjects treated with naftifine and 38{\%} of those treated with its vehicle had negative microscopic findings and negative fungal cultures (p=0.038). Two weeks after the conclusion of treatment (week 6), 62{\%} of the naftifine group and 29{\%} of the vehicle group had negative mycological findings (p=0.002). Naftfine was significantly more effective than its vehicle in reducing fungal scaling and fissuring (p<0.04). It was concluded that naftifine cream 1{\%} is safe and significantly more effective than its vehicle in treating tinea pedis.",
author = "Schachner, {Lawrence A} and Bagatell, {F. K.} and Whittington, {C. V.} and I. Willis and J. Sefton and DeGryse, {R. E.}",
year = "1990",
language = "English (US)",
volume = "7",
pages = "148--152",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "3",

}

TY - JOUR

T1 - The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis

AU - Schachner, Lawrence A

AU - Bagatell, F. K.

AU - Whittington, C. V.

AU - Willis, I.

AU - Sefton, J.

AU - DeGryse, R. E.

PY - 1990

Y1 - 1990

N2 - Naftifine cream 1% was compared with its vehicle during a 6-week, double-blind, randomized, parallel-group study of 91 subjects with tinea pedis. After 4 weeks of twice-daily treatment, 57% of the subjects treated with naftifine and 38% of those treated with its vehicle had negative microscopic findings and negative fungal cultures (p=0.038). Two weeks after the conclusion of treatment (week 6), 62% of the naftifine group and 29% of the vehicle group had negative mycological findings (p=0.002). Naftfine was significantly more effective than its vehicle in reducing fungal scaling and fissuring (p<0.04). It was concluded that naftifine cream 1% is safe and significantly more effective than its vehicle in treating tinea pedis.

AB - Naftifine cream 1% was compared with its vehicle during a 6-week, double-blind, randomized, parallel-group study of 91 subjects with tinea pedis. After 4 weeks of twice-daily treatment, 57% of the subjects treated with naftifine and 38% of those treated with its vehicle had negative microscopic findings and negative fungal cultures (p=0.038). Two weeks after the conclusion of treatment (week 6), 62% of the naftifine group and 29% of the vehicle group had negative mycological findings (p=0.002). Naftfine was significantly more effective than its vehicle in reducing fungal scaling and fissuring (p<0.04). It was concluded that naftifine cream 1% is safe and significantly more effective than its vehicle in treating tinea pedis.

UR - http://www.scopus.com/inward/record.url?scp=0025153590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025153590&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 148

EP - 152

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 3

ER -